Nabriva Therapeutics plc

(NASDAQ:NBRV)

Latest On Nabriva Therapeutics plc (NBRV):

Date/Time Type Description Signal Details
2023-02-06 20:31 ESTNewsMerck, Nabriva terminate distribution agreement for antibacterialN/A
2022-11-28 15:18 ESTNewsNabriva Therapeutics rallies on positive topline results from Phase 1 trial of XENLETAN/A
2022-11-28 15:18 ESTNewsNabriva gains after announcing Phase 1 data for cystic fibrosis candidateN/A
2022-11-13 20:22 ESTNewsNabriva Therapeutics plc (NBRV) Q3 2022 Earnings Call TranscriptN/A
2022-11-10 20:37 ESTNewsNabriva Therapeutics GAAP EPS of -$4.21 misses by $0.18, revenue of $9.15M misses by $1.53MN/A
2022-09-15 19:36 ESTNewsNabriva Therapeutics to effect 1-for-25 reverse stock splitN/A
2022-08-03 23:50 ESTNewsNabriva Therapeutics GAAP EPS of -$0.18 beats by $0.02, revenue of $9.19M beats by $0.66MN/A
2022-08-03 23:49 ESTNewsNabriva Therapeutics plc (NBRV) CEO Ted Schroeder on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-02 18:40 ESTNewsNabriva Therapeutics Q2 2022 Earnings PreviewN/A
2022-07-18 15:38 ESTNewsNabriva stock soars 19% on distribution deal with Er-Kim for bacterial pneumonia drug XenletaN/A
2022-05-08 19:47 ESTNewsNabriva Therapeutics plc (NBRV) CEO Ted Schroeder on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-06 05:36 ESTNewsNabriva extends exclusive contract to sell Merck's antibacterial drug Sivextro in USN/A
2022-05-06 05:35 ESTNewsNabriva Therapeutics GAAP EPS of -$0.20 misses by $0.01, revenue of $8.02M misses by $1.55MN/A
2022-05-05 06:42 ESTNewsNabriva Therapeutics Q1 2022 Earnings PreviewN/A
2022-03-30 21:27 ESTNewsNorthland Securities slashes Nabriva Therapeutics' price targetN/A
2022-03-30 04:50 ESTNewsNabriva Therapeutics GAAP EPS of -$0.24, revenue of $9.26MN/A
2022-03-30 04:50 ESTNewsNabriva 4Q results indicate slowdown in topline growthN/A
2022-03-30 04:50 ESTNewsNabriva Therapeutics plc (NBRV) CEO Ted Schroeder on Q4 2021 Results - Earnings Call TranscriptN/A
2022-03-30 04:50 ESTNewsNabriva Therapeutics plc 2021 Q4 - Results - Earnings Call PresentationN/A
2022-03-29 05:59 ESTNewsNabriva Therapeutics Q4 2021 Earnings PreviewN/A
2021-11-29 11:43 ESTNewsNabriva Therapeutics' lefamulin application accepted for review in ChinaN/A
2021-11-10 12:36 ESTNewsNabriva Therapeutics EPS beats by $0.01, beats on revenueN/A
2021-11-10 12:35 ESTNewsNabriva Therapeutics plc (NBRV) CEO Theodore Schroeder on Q3 2021 Results - Earnings Call TranscriptN/A
2021-11-10 12:35 ESTNewsNabriva Therapeutics plc 2021 Q3 - Results - Earnings Call PresentationN/A
2021-11-09 13:31 ESTNewsNabriva Therapeutics Q3 2021 Earnings PreviewN/A
2021-11-02 00:54 ESTNewsNabriva Therapeutics reports inducement grant to CMON/A
2021-10-01 18:21 ESTNewsNabriva Therapeutics hires Chief Medical OfficerN/A
2021-09-10 05:07 ESTNewsNabriva inks deal to make Xenleta available to Vizient’s pharmacy network programN/A
2021-09-08 12:54 ESTNewsNabriva shares rise after Xenleta approval in TaiwanN/A
2021-08-10 08:20 ESTNewsNabriva Therapeutics plc 2021 Q2 - Results - Earnings Call PresentationN/A
2021-08-07 03:49 ESTNewsNabriva Therapeutics plc (NBRV) CEO Ted Schroeder on Q2 2021 Results - Earnings Call TranscriptN/A
2021-08-06 07:28 ESTNewsNabriva Therapeutics EPS beats by $0.06, beats on revenueN/A
2021-07-21 16:58 ESTNewsNabriva antibiotic meets primary endpoint in phase 3 trial; shares soar 40%N/A
2021-07-21 16:54 ESTNewsNabriva Therapeutics extends principal debt repayments leading to cash runway extensionN/A
2021-05-07 12:24 ESTNewsNabriva Therapeutics EPS beats by $0.14, beats on revenueN/A
2021-04-15 23:22 ESTNewsNabriva commences exclusive distribution of SIVEXTRO in the U.S.N/A
2021-03-16 21:29 ESTAnalyst RatingThe Analyst Target Price has decreased from $9 to $6.Neutral
2021-03-12 08:10 ESTFinancialsCompany financials have been released.Neutral
2021-03-12 07:50 ESTNewsNabriva Therapeutics EPS misses by $0.33, beats on revenueN/A
2021-03-12 07:49 ESTNewsNabriva Therapeutics PLC (NBRV) CEO Theodore Schroeder on Q4 2020 Results - Earnings Call TranscriptN/A
2021-03-12 04:16 ESTEarnings EstimateAn EPS average of -$1.77 is estimated for the 2022 year.Sell
2021-03-12 04:16 ESTEarnings EstimateAn EPS average of -$0.70 is estimated for the quarter ending on June 30, 2021.Buy
2021-03-01 21:18 ESTNewsNabriva Therapeutics under pressure on $25.4M registered direct offeringN/A
2021-02-26 23:01 ESTNewsNabriva names Daniel Dolan CFON/A
2021-02-01 17:16 ESTNewsNabriva Therapeutics announces CFO retirementN/A
2021-01-06 16:16 ESTFinancialsCompany financials have been released.Neutral
2020-12-11 12:14 ESTAnalyst RatingThe Analyst Target Price has decreased from $14.5 to $9.Neutral
2020-12-11 09:20 ESTNewsNabriva Therapeutics prices $15M public offeringN/A
2020-12-08 12:25 ESTAnalyst RatingThe Analyst Target Price has decreased from $17.5 to $14.5.Neutral
2020-12-08 08:59 ESTNewsNabriva Therapeutics shares gain as Sinovant expands Xenleta support in ChinaN/A

About Nabriva Therapeutics plc (NBRV):

Nabriva Therapeutics plc, a biopharmaceutical company, engages in the development and commercialization of novel anti-infective agents to treat serious infections. The company's product includes XENLETA, a semi-synthetic pleuromutilin antibiotic for the treatment of community-acquired bacterial pneumonia; and SIVEXTRO, an oxazolidinone-class antibacterial for the treatment of acute bacterial skin and skin structure infection (ABSSSI). It also develops XENLETA that is in Phase I clinical trial for the treatment of pediatric infections, as well as sexually transmitted infections, cystic fibrosis, ABSSSI, ventilator-associated bacterial pneumonia, hospital-acquired bacterial pneumonia, osteomyelitis, and prosthetic joint infections. In addition, the company develops CONTEPO, an epoxide antibiotic for use in treating complicated urinary tract infections, as well as is in Phase I clinical trial for peri-operative prophylaxis. The company was formerly known as Nabriva Therapeutics Forschungs GmbH and changed its name to Nabriva Therapeutics plc in 2007. Nabriva Therapeutics plc was incorporated in 2005 and is headquartered in Dublin, Ireland.

NBRV Quotes by TradingView

See Advanced Chart

General

  • Name Nabriva Therapeutics plc
  • Symbol NBRV
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 72
  • Last Split Factor1:10
  • Last Split Date2020-12-03
  • Fiscal Year EndDecember
  • IPO Date2015-09-18
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryPharmaceuticals
  • Gic SubIndustryPharmaceuticals
  • Web URLhttp://www.nabriva.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 26.22
  • Price/Book (Most Recent Quarter) 1.52
  • Enterprise Value Revenue 20.07
  • Enterprise Value EBITDA 0.04
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$2.02
  • Next Year EPS Estimate -$1.17
  • Operating Margin -1315%
  • Return on Assets -54%
  • Return on Equity -187%
  • Revenue 5.03 million
  • Earnings Per Share -$1.88
  • Revenue Per Share $0.39
  • Gross Profit -10841000
  • Quarterly Earnings Growth 638.7%
View More

Highlights

  • Market Capitalization 73.26 million
  • EBITDA -91483000
  • PEG Ratio -0.06
  • Analyst Target Price $6
  • Book Value Per Share $1.57
View More

Share Statistics

  • Shares Outstanding 34.79 million
  • Shares Float 24.75 million
  • % Held by Insiders 45%
  • % Held by Institutions 20.73%
  • Shares Short 1.62 million
  • Shares Short Prior Month 1.28 million
  • Short Ratio 1.08
  • Short % of Float 6%
  • Short % of Shares Outstanding 6%
View More

Technicals

  • Beta 1.9
  • 52 Week High $12
  • 52 Week Low $1.52
  • 50 Day Moving Average 2.5
  • 200 Day Moving Average 3.91
View More

Dividends

  • Dividend Date 2020-12-03
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Nabriva Therapeutics plc (NBRV) Dividend Calendar:

NBRV's last dividend payment was made to shareholders on December 3, 2020.

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Nabriva Therapeutics plc (NBRV) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-03-11$2.46 million-$1.11-$0.94-18.09%
2020-09-302020-11-05$N/A-$0.90-$0.987.69%
2020-06-302020-08-06$N/A-$1.40-$1.6012.5%
2020-03-312020-05-11$301000-$2.17-$2.5515.01%
2019-12-312020-03-12$333000-$2.90-$3.4515.94%
2019-09-302019-11-12$6.92 million-$2.40-$3.0721.74%
2019-06-302019-08-08$525000-$3.00-$3.3710.89%
2019-03-312019-05-10$1.7 million-$2.90-$3.3012.12%
2018-12-312019-03-12$797000-$4.10-$3.15-30.16%
2018-09-302018-11-06$461000-$9.00-$3.30-172.73%
2018-06-302018-08-09$847000-$4.40-$5.0012%
2018-03-312018-05-08$7.55 million-$3.60-$5.7036.84%
2017-12-312018-03-16$1.12 million-$6.00-$5.80-3.45%
2017-09-302017-11-09$1.47 million-$7.90-$5.93-33.33%
2017-06-302017-08-07$1.05 million-$5.40-$5.501.82%
2017-03-312017-05-10$1.68 million-$0.56-$5.4889.78%
2016-12-312017-03-24$2.31 million-$0.69-$0.57-21.05%
2016-09-302016-11-16$971000-$0.66-$2.5373.91%
2016-06-302016-08-09$1.79 million-$0.56-$5.6490.07%
2016-03-312016-04-27$1.42 million-$0.66-$0.7613.16%
2015-09-302015-11-10$N/A-$0.18

Nabriva Therapeutics plc (NBRV) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Nabriva Therapeutics plc (NBRV) Chart:

Nabriva Therapeutics plc (NBRV) News:

Below you will find a list of latest news for Nabriva Therapeutics plc (NBRV) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Nabriva Therapeutics plc (NBRV) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent

Latest NBRV Trades:

Date Shares Price
Jun 13, 2022 3:15 PM EST540$0.2

Nabriva Therapeutics plc (NBRV) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641640/000110465920080578/0001104659-20-080578-index.htm
2020-09-08UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1641640/000000000020008431/0000000000-20-008431-index.htm
2020-02-07SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1641640/000031506620001103/0000315066-20-001103-index.htm
2018-08-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1641640/000090221918000484/0000902219-18-000484-index.htm
2019-02-08SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1641640/000090221919000015/0000902219-19-000015-index.htm
2019-02-11SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1641640/000090221919000021/0000902219-19-000021-index.htm
2019-12-06SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1641640/000094787119000896/0000947871-19-000896-index.htm
2019-12-26SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1641640/000094787119000987/0000947871-19-000987-index.htm
2018-09-10PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/1641640/000104746918006094/0001047469-18-006094-index.htm
2018-10-01DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1641640/000104746918006504/0001047469-18-006504-index.htm
2019-03-1210-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1641640/000104746919001138/0001047469-19-001138-index.htm
2019-06-14DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1641640/000104746919003649/0001047469-19-003649-index.htm
2019-06-25424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1641640/000104746919003866/0001047469-19-003866-index.htm
2019-12-20424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1641640/000104746919006929/0001047469-19-006929-index.htm
2020-06-01424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1641640/000104746920003278/0001047469-20-003278-index.htm
2020-06-01424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1641640/000104746920003282/0001047469-20-003282-index.htm
2020-06-12PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/1641640/000104746920003566/0001047469-20-003566-index.htm
2020-06-25DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1641640/000104746920003859/0001047469-20-003859-index.htm
2020-09-01424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1641640/000104746920004734/0001047469-20-004734-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1641640/000107261319000088/0001072613-19-000088-index.htm
2018-08-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641640/000110465918049250/0001104659-18-049250-index.htm
2018-08-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641640/000110465918049251/0001104659-18-049251-index.htm
2018-08-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641640/000110465918049252/0001104659-18-049252-index.htm
2018-08-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641640/000110465918049576/0001104659-18-049576-index.htm
2018-08-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1641640/000110465918050163/0001104659-18-050163-index.htm
2018-08-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1641640/000110465918050795/0001104659-18-050795-index.htm
2018-08-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1641640/000110465918050835/0001104659-18-050835-index.htm
2018-09-108-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/1641640/000110465918056032/0001104659-18-056032-index.htm
2018-10-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1641640/000110465918065105/0001104659-18-065105-index.htm
2018-10-31S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1641640/000110465918065109/0001104659-18-065109-index.htm
2018-11-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1641640/000110465918066192/0001104659-18-066192-index.htm
2018-11-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1641640/000110465918066303/0001104659-18-066303-index.htm
2018-12-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1641640/000110465918074266/0001104659-18-074266-index.htm
2018-12-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641640/000110465918074905/0001104659-18-074905-index.htm
2019-01-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1641640/000110465919000791/0001104659-19-000791-index.htm
2019-01-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1641640/000110465919001838/0001104659-19-001838-index.htm
2019-02-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641640/000110465919005516/0001104659-19-005516-index.htm
2019-02-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641640/000110465919005519/0001104659-19-005519-index.htm
2019-02-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641640/000110465919005520/0001104659-19-005520-index.htm
2019-02-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641640/000110465919005521/0001104659-19-005521-index.htm
2019-02-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641640/000110465919005522/0001104659-19-005522-index.htm
2019-02-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641640/000110465919005523/0001104659-19-005523-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1641640/000110465919008799/0001104659-19-008799-index.htm
2019-02-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1641640/000110465919009191/0001104659-19-009191-index.htm
2019-03-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1641640/000110465919014080/0001104659-19-014080-index.htm
2019-03-12S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1641640/000110465919014287/0001104659-19-014287-index.htm
2019-04-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1641640/000110465919018855/0001104659-19-018855-index.htm
2019-05-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1641640/000110465919025701/0001104659-19-025701-index.htm
2019-05-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1641640/000110465919028448/0001104659-19-028448-index.htm
2019-05-1010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1641640/000110465919028565/0001104659-19-028565-index.htm
2019-06-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1641640/000110465919036587/0001104659-19-036587-index.htm
2019-06-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1641640/000110465919037436/0001104659-19-037436-index.htm
2019-07-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1641640/000110465919041742/0001104659-19-041742-index.htm
2019-07-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641640/000110465919041878/0001104659-19-041878-index.htm
2019-08-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641640/000110465919043340/0001104659-19-043340-index.htm
2019-08-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641640/000110465919043342/0001104659-19-043342-index.htm
2019-08-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641640/000110465919043343/0001104659-19-043343-index.htm
2019-08-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641640/000110465919043344/0001104659-19-043344-index.htm
2019-08-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641640/000110465919043345/0001104659-19-043345-index.htm
2019-08-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641640/000110465919043346/0001104659-19-043346-index.htm
2019-08-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641640/000110465919043347/0001104659-19-043347-index.htm
2019-08-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1641640/000110465919043927/0001104659-19-043927-index.htm
2019-08-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1641640/000110465919044731/0001104659-19-044731-index.htm
2019-08-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1641640/000110465919044881/0001104659-19-044881-index.htm
2019-08-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1641640/000110465919046525/0001104659-19-046525-index.htm
2019-08-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641640/000110465919046854/0001104659-19-046854-index.htm
2019-08-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641640/000110465919046855/0001104659-19-046855-index.htm
2019-08-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641640/000110465919046856/0001104659-19-046856-index.htm
2019-08-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641640/000110465919046857/0001104659-19-046857-index.htm
2019-08-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641640/000110465919046858/0001104659-19-046858-index.htm
2019-08-264/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641640/000110465919047347/0001104659-19-047347-index.htm
2019-08-264/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641640/000110465919047348/0001104659-19-047348-index.htm
2019-08-264/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641640/000110465919047349/0001104659-19-047349-index.htm
2019-08-264/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641640/000110465919047350/0001104659-19-047350-index.htm
2019-08-264/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641640/000110465919047351/0001104659-19-047351-index.htm
2019-08-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641640/000110465919047352/0001104659-19-047352-index.htm
2019-08-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641640/000110465919047723/0001104659-19-047723-index.htm
2019-09-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641640/000110465919048436/0001104659-19-048436-index.htm
2019-09-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1641640/000110465919049328/0001104659-19-049328-index.htm
2019-09-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1641640/000110465919051550/0001104659-19-051550-index.htm
2019-11-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1641640/000110465919062629/0001104659-19-062629-index.htm
2019-12-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1641640/000110465919074617/0001104659-19-074617-index.htm
2019-12-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1641640/000110465919074693/0001104659-19-074693-index.htm
2019-12-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1641640/000110465919075598/0001104659-19-075598-index.htm
2020-01-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1641640/000110465920002277/0001104659-20-002277-index.htm
2020-02-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641640/000110465920010896/0001104659-20-010896-index.htm
2020-02-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641640/000110465920010897/0001104659-20-010897-index.htm
2020-02-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641640/000110465920010899/0001104659-20-010899-index.htm
2020-02-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641640/000110465920010900/0001104659-20-010900-index.htm
2020-02-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641640/000110465920010901/0001104659-20-010901-index.htm
2020-02-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641640/000110465920010902/0001104659-20-010902-index.htm
2020-02-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641640/000110465920015171/0001104659-20-015171-index.htm
2020-02-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641640/000110465920015172/0001104659-20-015172-index.htm
2020-02-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641640/000110465920015173/0001104659-20-015173-index.htm
2020-02-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641640/000110465920015174/0001104659-20-015174-index.htm
2020-02-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641640/000110465920015176/0001104659-20-015176-index.htm
2020-02-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641640/000110465920015178/0001104659-20-015178-index.htm
2020-02-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1641640/000110465920019213/0001104659-20-019213-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641640/000110465920028847/0001104659-20-028847-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641640/000110465920028848/0001104659-20-028848-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641640/000110465920028849/0001104659-20-028849-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641640/000110465920028850/0001104659-20-028850-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641640/000110465920028851/0001104659-20-028851-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641640/000110465920028852/0001104659-20-028852-index.htm
2020-03-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1641640/000110465920032466/0001104659-20-032466-index.htm
2020-04-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641640/000110465920042578/0001104659-20-042578-index.htm
2020-04-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641640/000110465920042579/0001104659-20-042579-index.htm
2020-04-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641640/000110465920042580/0001104659-20-042580-index.htm
2020-04-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641640/000110465920042581/0001104659-20-042581-index.htm
2020-04-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641640/000110465920042582/0001104659-20-042582-index.htm
2020-04-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641640/000110465920042583/0001104659-20-042583-index.htm
2020-04-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1641640/000110465920044193/0001104659-20-044193-index.htm
2020-05-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1641640/000110465920055666/0001104659-20-055666-index.htm
2020-05-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641640/000110465920056348/0001104659-20-056348-index.htm
2020-05-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641640/000110465920056349/0001104659-20-056349-index.htm
2020-05-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641640/000110465920056350/0001104659-20-056350-index.htm
2020-05-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641640/000110465920056351/0001104659-20-056351-index.htm
2020-05-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641640/000110465920056352/0001104659-20-056352-index.htm
2020-05-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641640/000110465920056355/0001104659-20-056355-index.htm
2020-05-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1641640/000110465920059553/0001104659-20-059553-index.htm
2020-05-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1641640/000110465920066371/0001104659-20-066371-index.htm
2020-05-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1641640/000110465920067379/0001104659-20-067379-index.htm
2020-06-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1641640/000110465920067962/0001104659-20-067962-index.htm
2020-06-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641640/000110465920069178/0001104659-20-069178-index.htm
2020-06-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641640/000110465920069179/0001104659-20-069179-index.htm
2020-06-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641640/000110465920069180/0001104659-20-069180-index.htm
2020-06-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641640/000110465920069182/0001104659-20-069182-index.htm
2020-06-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641640/000110465920069184/0001104659-20-069184-index.htm
2020-06-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641640/000110465920069188/0001104659-20-069188-index.htm
2020-06-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1641640/000110465920075453/0001104659-20-075453-index.htm
2020-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641640/000110465920080539/0001104659-20-080539-index.htm
2020-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641640/000110465920080540/0001104659-20-080540-index.htm
2020-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641640/000110465920080541/0001104659-20-080541-index.htm
2020-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641640/000110465920080542/0001104659-20-080542-index.htm
2020-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641640/000110465920080544/0001104659-20-080544-index.htm
2020-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641640/000110465920080578/0001104659-20-080578-index.htm
2020-07-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1641640/000110465920083753/0001104659-20-083753-index.htm
2020-07-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1641640/000110465920087993/0001104659-20-087993-index.htm
2020-07-30S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1641640/000110465920087999/0001104659-20-087999-index.htm
2020-07-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641640/000110465920089136/0001104659-20-089136-index.htm
2020-07-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641640/000110465920089139/0001104659-20-089139-index.htm
2020-07-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641640/000110465920089140/0001104659-20-089140-index.htm
2020-07-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641640/000110465920089141/0001104659-20-089141-index.htm
2020-07-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641640/000110465920089143/0001104659-20-089143-index.htm
2020-07-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641640/000110465920089144/0001104659-20-089144-index.htm
2020-08-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641640/000110465920090278/0001104659-20-090278-index.htm
2020-08-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641640/000110465920090281/0001104659-20-090281-index.htm
2020-08-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641640/000110465920090282/0001104659-20-090282-index.htm
2020-08-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641640/000110465920090283/0001104659-20-090283-index.htm
2020-08-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641640/000110465920090332/0001104659-20-090332-index.htm
2020-08-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641640/000110465920090334/0001104659-20-090334-index.htm
2020-08-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641640/000110465920097716/0001104659-20-097716-index.htm
2020-08-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641640/000110465920097717/0001104659-20-097717-index.htm
2020-08-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641640/000110465920097718/0001104659-20-097718-index.htm
2020-08-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641640/000110465920097719/0001104659-20-097719-index.htm
2020-08-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641640/000110465920097720/0001104659-20-097720-index.htm
2020-09-01S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1641640/000110465920101436/0001104659-20-101436-index.htm
2020-09-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1641640/000110465920101445/0001104659-20-101445-index.htm
2020-09-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641640/000110465920101903/0001104659-20-101903-index.htm
2020-09-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641640/000110465920101905/0001104659-20-101905-index.htm
2020-09-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641640/000110465920101906/0001104659-20-101906-index.htm
2020-09-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641640/000110465920101907/0001104659-20-101907-index.htm
2020-09-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641640/000110465920101908/0001104659-20-101908-index.htm
2020-09-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641640/000110465920101909/0001104659-20-101909-index.htm
2020-09-09CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1641640/000110465920103455/0001104659-20-103455-index.htm
2020-10-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641640/000110465920111074/0001104659-20-111074-index.htm
2020-10-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641640/000110465920111075/0001104659-20-111075-index.htm
2020-10-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641640/000110465920111076/0001104659-20-111076-index.htm
2020-10-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641640/000110465920111077/0001104659-20-111077-index.htm
2020-10-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641640/000110465920111079/0001104659-20-111079-index.htm
2020-10-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641640/000110465920111080/0001104659-20-111080-index.htm
2020-11-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641640/000110465920120638/0001104659-20-120638-index.htm
2020-11-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641640/000110465920120639/0001104659-20-120639-index.htm
2020-11-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641640/000110465920120640/0001104659-20-120640-index.htm
2020-11-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641640/000110465920120641/0001104659-20-120641-index.htm
2020-11-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641640/000110465920120642/0001104659-20-120642-index.htm
2018-08-07SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1641640/000114420418042472/0001144204-18-042472-index.htm
2018-08-03SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1641640/000119312518236943/0001193125-18-236943-index.htm
2019-02-01SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1641640/000119312519025367/0001193125-19-025367-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1641640/000119312519040450/0001193125-19-040450-index.htm
2019-07-01SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1641640/000119312519187447/0001193125-19-187447-index.htm
2020-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1641640/000119312520033287/0001193125-20-033287-index.htm
2019-11-1210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1641640/000155837019010818/0001558370-19-010818-index.htm
2020-03-1210-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1641640/000155837020002547/0001558370-20-002547-index.htm
2020-05-1110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1641640/000155837020006259/0001558370-20-006259-index.htm
2020-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1641640/000155837020009633/0001558370-20-009633-index.htm
2020-08-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1641640/000155837020009653/0001558370-20-009653-index.htm
2020-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1641640/000155837020012839/0001558370-20-012839-index.htm
2020-11-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1641640/000155837020012847/0001558370-20-012847-index.htm
2018-08-06SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1641640/000161577418007607/0001615774-18-007607-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1641640/000161577419002502/0001615774-19-002502-index.htm
2019-08-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1641640/000161577419011241/0001615774-19-011241-index.htm
2020-09-11EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1641640/999999999520002426/9999999995-20-002426-index.htm
2018-08-03CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1641640/999999999718007156/9999999997-18-007156-index.htm
2018-11-29CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1641640/999999999718009158/9999999997-18-009158-index.htm
2019-03-25CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1641640/999999999719001943/9999999997-19-001943-index.htm
2020-02-06SEC STAFF SEC Staff Letter: REDACTED EXHIBIThttps://www.sec.gov/Archives/edgar/data/1641640/999999999720000557/9999999997-20-000557-index.htm
2020-02-19SEC STAFF SEC Staff Letter: REDACTED EXHIBIThttps://www.sec.gov/Archives/edgar/data/1641640/999999999720000793/9999999997-20-000793-index.htm

Nabriva Therapeutics plc (NBRV) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Nabriva Therapeutics plc (NBRV). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 45%
Institutional Ownership: 2073%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2019-08-27Theodore R SchroederChief Executive OfficerBuy50,000.001.7989,500.00117,489.00https://www.sec.gov/Archives/edgar/data/1641640/000110465919047723/0001104659-19-047723-index.htm
2019-08-19Colin MD BroomDirectorBuy33,750.00135,901.00https://www.sec.gov/Archives/edgar/data/1641640/000110465919046857/0001104659-19-046857-index.htm
2019-08-19Francesco Maria LavinoChief Commercial OfficerBuy11,250.0014,969.00https://www.sec.gov/Archives/edgar/data/1641640/000110465919046855/0001104659-19-046855-index.htm
2020-02-06Jennifer SchranzChief Medical OfficerBuy105,000.00158,705.00https://www.sec.gov/Archives/edgar/data/1641640/000110465920015178/0001104659-20-015178-index.htm
2019-08-22Francesco Maria LavinoChief Commercial OfficerBuy4,800.002.049,780.0015,972.00https://www.sec.gov/Archives/edgar/data/1641640/000110465919047352/0001104659-19-047352-index.htm
2020-07-29Carrie L. BourdowDirectorBuy17,500.0017,500.00https://www.sec.gov/Archives/edgar/data/1641640/000110465920089144/0001104659-20-089144-index.htm
2020-02-06Francesco Maria LavinoChief Commercial OfficerBuy105,000.00180,830.00https://www.sec.gov/Archives/edgar/data/1641640/000110465920015173/0001104659-20-015173-index.htm
2020-02-06Gary SenderChief Financial OfficerBuy105,000.00183,669.00https://www.sec.gov/Archives/edgar/data/1641640/000110465920015174/0001104659-20-015174-index.htm
2020-02-06Robert CrottyGen Counsel & Corp SecretaryBuy105,000.00188,097.00https://www.sec.gov/Archives/edgar/data/1641640/000110465920015171/0001104659-20-015171-index.htm
2020-08-19Francesco Maria LavinoChief Commercial OfficerBuy11,250.00189,884.00https://www.sec.gov/Archives/edgar/data/1641640/000110465920097719/0001104659-20-097719-index.htm
2020-08-19Robert CrottyGen Counsel & Corp SecretaryBuy11,250.00208,669.00https://www.sec.gov/Archives/edgar/data/1641640/000110465920097718/0001104659-20-097718-index.htm
2019-08-30Colin MD BroomDirectorBuy10,177.002.0320,668.47208,750.00https://www.sec.gov/Archives/edgar/data/1641640/000110465919048436/0001104659-19-048436-index.htm
2020-08-19Gary SenderChief Financial OfficerBuy11,250.00210,180.00https://www.sec.gov/Archives/edgar/data/1641640/000110465920097716/0001104659-20-097716-index.htm
2019-08-19Gary SenderChief Financial OfficerBuy11,250.0022,604.00https://www.sec.gov/Archives/edgar/data/1641640/000110465919046858/0001104659-19-046858-index.htm
2020-07-29Colin MD BroomDirectorBuy17,500.00226,250.00https://www.sec.gov/Archives/edgar/data/1641640/000110465920089136/0001104659-20-089136-index.htm
2020-08-20Colin MD BroomDirectorSell11,064.000.657,165.05248,936.00https://www.sec.gov/Archives/edgar/data/1641640/000110465920097717/0001104659-20-097717-index.htm
2020-07-29Stephen W WebsterDirectorBuy17,500.0025,500.00https://www.sec.gov/Archives/edgar/data/1641640/000110465920089143/0001104659-20-089143-index.htm
2020-08-19Colin MD BroomDirectorBuy33,750.00260,000.00https://www.sec.gov/Archives/edgar/data/1641640/000110465920097717/0001104659-20-097717-index.htm
2019-08-19Robert CrottyGen Counsel & Corp SecretaryBuy11,250.0027,036.00https://www.sec.gov/Archives/edgar/data/1641640/000110465919046856/0001104659-19-046856-index.htm
2020-02-06Steven P. GelonePresident & COOBuy155,000.00326,919.00https://www.sec.gov/Archives/edgar/data/1641640/000110465920015176/0001104659-20-015176-index.htm
2019-08-19Steven P. GelonePresident and COOBuy11,250.0033,776.00https://www.sec.gov/Archives/edgar/data/1641640/000110465919046854/0001104659-19-046854-index.htm
2020-08-19Steven P. GelonePresident and COOBuy11,250.00352,199.00https://www.sec.gov/Archives/edgar/data/1641640/000110465920097720/0001104659-20-097720-index.htm
2018-07-31DANIEL D BURGESSDirectorBuy36,000.002.7599,000.0036,000.00https://www.sec.gov/Archives/edgar/data/1641640/000110465918049250/0001104659-18-049250-index.htm
2020-08-19Steven P. GelonePresident and COOBuy16,000.00368,199.00https://www.sec.gov/Archives/edgar/data/1641640/000110465920097720/0001104659-20-097720-index.htm
2018-07-31George Harrison TalbotDirectorBuy14,500.002.7539,875.0047,640.00https://www.sec.gov/Archives/edgar/data/1641640/000110465918049251/0001104659-18-049251-index.htm
2018-12-24Charles A Jr RowlandDirectorBuy53,000.001.3169,430.0053,000.00https://www.sec.gov/Archives/edgar/data/1641640/000110465918074905/0001104659-18-074905-index.htm
2020-07-29DANIEL D BURGESSDirectorBuy17,500.0053,500.00https://www.sec.gov/Archives/edgar/data/1641640/000110465920089139/0001104659-20-089139-index.htm
2019-08-19Steven P. GelonePresident and COOBuy16,000.0055,776.00https://www.sec.gov/Archives/edgar/data/1641640/000110465919046854/0001104659-19-046854-index.htm
2020-02-06Theodore R SchroederChief Executive OfficerBuy343,800.00646,560.00https://www.sec.gov/Archives/edgar/data/1641640/000110465920015172/0001104659-20-015172-index.htm
2020-07-29George Harrison TalbotDirectorBuy17,500.0065,140.00https://www.sec.gov/Archives/edgar/data/1641640/000110465920089140/0001104659-20-089140-index.htm
2019-07-25Theodore R SchroederChief Executive OfficerBuy6,748.0067,489.00https://www.sec.gov/Archives/edgar/data/1641640/000110465919041878/0001104659-19-041878-index.htm
2020-07-29Charles A Jr RowlandDirectorBuy17,500.0070,500.00https://www.sec.gov/Archives/edgar/data/1641640/000110465920089141/0001104659-20-089141-index.htm